These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 28005498)

  • 41. Implications of NSF-active and NSF-inert in nephrogenic systemic fibrosis.
    Wiginton CD
    AJR Am J Roentgenol; 2008 Dec; 191(6):1864-6. PubMed ID: 19020261
    [No Abstract]   [Full Text] [Related]  

  • 42. Gadolinium-based Contrast Agent Accumulates in the Brain Even in Subjects without Severe Renal Dysfunction: Evaluation of Autopsy Brain Specimens with Inductively Coupled Plasma Mass Spectroscopy.
    Kanda T; Fukusato T; Matsuda M; Toyoda K; Oba H; Kotoku J; Haruyama T; Kitajima K; Furui S
    Radiology; 2015 Jul; 276(1):228-32. PubMed ID: 25942417
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Gadolinium retention in the body: what we know and what we can do.
    Tedeschi E; Caranci F; Giordano F; Angelini V; Cocozza S; Brunetti A
    Radiol Med; 2017 Aug; 122(8):589-600. PubMed ID: 28361260
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Physicochemical properties of gadoteridol and other magnetic resonance contrast agents.
    Tweedle MF
    Invest Radiol; 1992 Aug; 27 Suppl 1():S2-6. PubMed ID: 1506149
    [No Abstract]   [Full Text] [Related]  

  • 45. Gadolinium-complexed Aβ-binding contrast agents for MRI diagnosis of Alzheimer's Disease.
    Matharu B; Spencer N; Howe F; Austen B
    Neuropeptides; 2015 Oct; 53():63-70. PubMed ID: 26234669
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Progressive increase of T1 signal intensity in the dentate nucleus and globus pallidus on unenhanced T1-weighted MR images in the pediatric brain exposed to multiple doses of gadolinium contrast.
    Roberts DR; Holden KR
    Brain Dev; 2016 Mar; 38(3):331-6. PubMed ID: 26345358
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Toward an image-guided microbeam radiation therapy using gadolinium-based nanoparticles.
    Le Duc G; Miladi I; Alric C; Mowat P; Bräuer-Krisch E; Bouchet A; Khalil E; Billotey C; Janier M; Lux F; Epicier T; Perriat P; Roux S; Tillement O
    ACS Nano; 2011 Dec; 5(12):9566-74. PubMed ID: 22040385
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Intraindividual in vivo comparison of gadolinium contrast agents for pharmacokinetic analysis using dynamic contrast enhanced magnetic resonance imaging.
    Liang J; Sammet S; Yang X; Jia G; Takayama Y; Knopp MV
    Invest Radiol; 2010 May; 45(5):233-44. PubMed ID: 20351653
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Convective distribution of macromolecules in the primate brain demonstrated using computerized tomography and magnetic resonance imaging.
    Nguyen TT; Pannu YS; Sung C; Dedrick RL; Walbridge S; Brechbiel MW; Garmestani K; Beitzel M; Yordanov AT; Oldfield EH
    J Neurosurg; 2003 Mar; 98(3):584-90. PubMed ID: 12650432
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Gadolinium concentration analysis in brain phantom by X-ray fluorescence.
    Almalki M; Majid SA; Butler PH; Reinisch L
    Australas Phys Eng Sci Med; 2010 Jun; 33(2):185-91. PubMed ID: 20596811
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Investigations into the physicochemical properties of dextran small particulate gadolinium oxide nanoparticles.
    McDonald MA; Watkin KL
    Acad Radiol; 2006 Apr; 13(4):421-7. PubMed ID: 16554221
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term in vivo biodistribution and toxicity of Gd(OH)3 nanorods.
    Yang Y; Sun Y; Liu Y; Peng J; Wu Y; Zhang Y; Feng W; Li F
    Biomaterials; 2013 Jan; 34(2):508-15. PubMed ID: 23099061
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Gadolinium deposition in the brain: another concern regarding gadolinium-based contrast agents.
    Karabulut N
    Diagn Interv Radiol; 2015; 21(4):269-70. PubMed ID: 26133320
    [No Abstract]   [Full Text] [Related]  

  • 54. [The rapid magnetic resonance tomography measurement of the contrast medium dilution kinetics (gadolinium-DTPA) in a circulatory phantom].
    Böck JC; Sander B; Frank J; Schörner W
    Rofo; 1991 Sep; 155(3):267-71. PubMed ID: 1912546
    [TBL] [Abstract][Full Text] [Related]  

  • 55. High Levels of Gadolinium Deposition in the Skin of a Patient With Normal Renal Function.
    Roberts DR; Lindhorst SM; Welsh CT; Maravilla KR; Herring MN; Braun KA; Thiers BH; Davis WC
    Invest Radiol; 2016 May; 51(5):280-9. PubMed ID: 26953564
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Pharmacokinetic behavior of gadoteridol injection.
    McLachlan SJ; Eaton S; De Simone DN
    Invest Radiol; 1992 Aug; 27 Suppl 1():S12-5. PubMed ID: 1506147
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical and biological consequences of transmetallation induced by contrast agents for magnetic resonance imaging: a review.
    Idée JM; Port M; Raynal I; Schaefer M; Le Greneur S; Corot C
    Fundam Clin Pharmacol; 2006 Dec; 20(6):563-76. PubMed ID: 17109649
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Nanoamplifiers synthesized from gadolinium and gold nanocomposites for magnetic resonance imaging.
    Tian X; Shao Y; He H; Liu H; Shen Y; Huang W; Li L
    Nanoscale; 2013 Apr; 5(8):3322-9. PubMed ID: 23467400
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gadolinium-staining reveals amyloid plaques in the brain of Alzheimer's transgenic mice.
    Petiet A; Santin M; Bertrand A; Wiggins CJ; Petit F; Houitte D; Hantraye P; Benavides J; Debeir T; Rooney T; Dhenain M
    Neurobiol Aging; 2012 Aug; 33(8):1533-44. PubMed ID: 21531045
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Linear Gadolinium-Based Contrast Agents Are Associated With Brain Gadolinium Retention in Healthy Rats.
    Robert P; Violas X; Grand S; Lehericy S; Idée JM; Ballet S; Corot C
    Invest Radiol; 2016 Feb; 51(2):73-82. PubMed ID: 26606549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.